Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes.
Animals
Diabetes Complications
/ physiopathology
Diabetes Mellitus
/ physiopathology
Dyslipidemias
/ complications
Ganglia, Spinal
/ metabolism
Heredodegenerative Disorders, Nervous System
/ complications
Humans
Hyperglycemia
/ complications
Mitochondrial Dynamics
/ physiology
Peripheral Nervous System Diseases
/ complications
Bioenergetics
Charcot-Marie-Tooth disease
Diabetes
Fission
Fusion
Hereditary neuropathy
Mitochondria
Mitochondrial associated membranes
Mitochondrial trafficking
Prediabetes
Journal
International review of neurobiology
ISSN: 2162-5514
Titre abrégé: Int Rev Neurobiol
Pays: United States
ID NLM: 0374740
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
19
6
2019
pubmed:
19
6
2019
medline:
21
1
2020
Statut:
ppublish
Résumé
Peripheral neuropathy is a common and debilitating complication of diabetes and prediabetes. Recent clinical studies have identified an association between the development of neuropathy and dyslipidemia in prediabetic and diabetic patients. Despite the prevalence of this complication, studies identifying molecular mechanisms that underlie neuropathy progression in prediabetes or diabetes are limited. However, dysfunctional mitochondrial pathways in hereditary neuropathy provide feasible molecular targets for assessing mitochondrial dysfunction in neuropathy associated with prediabetes or diabetes. Recent studies suggest that elevated levels of dietary saturated fatty acids (SFAs) associated with dyslipidemia impair mitochondrial dynamics in sensory neurons by inducing mitochondrial depolarization, compromising mitochondrial bioenergetics, and impairing axonal mitochondrial transport. This causes lower neuronal ATP and apoptosis. Conversely, monounsaturated fatty acids (MUFAs) restore nerve and sensory mitochondrial function. Understanding the mitochondrial pathways that contribute to neuropathy progression in prediabetes and diabetes may provide therapeutic targets for the treatment of this debilitating complication.
Identifiants
pubmed: 31208522
pii: S0074-7742(19)30018-2
doi: 10.1016/bs.irn.2019.05.002
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
127-176Subventions
Organisme : NIDDK NIH HHS
ID : F32 DK112642
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107956
Pays : United States
Informations de copyright
© 2019 Elsevier Inc. All rights reserved.